Merck Drugs Added To Sichuan Essential Drug List
This article was originally published in PharmAsia News
Executive SummaryMerck recently announced the addition of its originator drug Zocor to Sichuan province's essential drug list. With the addition of two types of the cardiovascular drug to the list, prices will be cut by more than 50 percent. This is the first foreign originator drug to enter the province's essential drug list, and cardiovascular specialist Zhang Ting-Jie hopes the example set by Merck will influence other drug companies to seek essential drug listing and bring cheap, high-quality drugs to the people. He also notes that cardiovascular disease has become China's most common disease, with more than 1 million hypertensive patients in the Chengdu region alone. (Click Here For More - Chinese Language
You may also be interested in...
Having had a very fruitful year in terms of regulatory approvals, the Swiss major will reveal how successful its new products have been commercially. Of particular interest will be the performance of eye drug Beovu as it takes on Bayer's rival Eylea.
Executives On The Move: New Picks For Finance Posts At Cambrex And Editas Medicine, And Zimmer Biomet Fills Communications Spot
Gene-editing company Editas Medicine appoints a new CFO, while Affimed and NexImmune bring new chief medical officers on board.
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.